RecruitingNot ApplicableNCT06868615

AVAVA MIRIA General Use


Sponsor

AVAVA, Inc.

Enrollment

200 participants

Start Date

Sep 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called AVAVA for people with acne, acne scars - mixed atrophic and hypertrophic, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAVAVA

1550nm Non-Ablative Fractional Laser


Locations(1)

AVAVA, Inc.

Waltham, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06868615


Related Trials